Related Experiment Video
Updated: Jan 13, 2026

09:55
Isolation and Characterization of the Immune Cells from Micro-dissected Mouse Choroid Plexuses
Published on: February 3, 2022
8.2K
Multi-modal choroid plexus pathology in aging and Alzheimer's disease
Biorxiv : the Preprint Server for Biology
|January 9, 2026
Summary
The choroid plexus (ChP) ages with fibrosis and calcification, worsening in Alzheimer's disease (AD). Macrophage and fibroblast dysfunction drives ChP barrier defects in aging and AD.
Area of Science:
- Neuroscience
- Pathology
- Aging Research
Background:
- Brain barriers, cerebrospinal fluid (CSF) dynamics, and peripheral factors are linked to Alzheimer's disease (AD).
- The choroid plexus (ChP) is a critical blood-brain interface producing CSF and forming the blood-CSF barrier.
- ChP pathology development across the lifespan and its contribution to AD remain undercharacterized.
Purpose of the Study:
- To systematically characterize choroid plexus (ChP) pathology across the lifespan and in Alzheimer's disease (AD).
- To integrate multi-modal data for a comprehensive understanding of ChP dysfunction.
Main Methods:
- Multi-modal atlas integrating single-nucleus transcriptomics from 49 individuals.
- AI-assisted quantitative histopathology on >500 postmortem samples (ages 16-105).
- Spatial transcriptomics and functional studies in 5xFAD mouse models.
Main Results:
- Identified fibrosis, calcification, and macrophage abnormalities as hallmarks of ChP aging.
- Observed AD pathology exacerbates ChP aging, expanding a pro-inflammatory fibroblast-macrophage signaling niche.
- Demonstrated macrophage dysfunction impairs epithelial barrier maintenance and repair in 5xFAD mice.
Conclusions:
- Established a foundational resource for studying ChP dysfunction in aging and AD.
- Proposed the macrophage-fibroblast-epithelial barrier axis as a key driver of ChP pathology.
- Highlighted the ChP's role in neurodegenerative disease pathogenesis.
Related Concept Videos
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Photoreceptors and Visual Pathways
8.7K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
8.7K

